FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2306075557> ?p ?o ?g. }

• W2306075557 endingPage "e89" @default.
• W2306075557 startingPage "e79" @default.
• W2306075557 abstract "To estimate the frequency of lower urinary tract symptoms (LUTS) and sexual dysfunction in patients with systemic sclerosis (SSc) and associate these symptoms with clinical and functional parameters including disability and quality of life. Patients with SSc seen in Cochin hospital, Paris, between February and April 2010 were assessed for disease type, LUTS by the Urinary Symptom Profile scale, sexual dysfunction by the Feminine Sexual Function Index (FSFI) and International Index for the Erectile Function (IIEF-5), global disability by the Health Assessment Questionnaire and McMaster Toronto Arthritis Patient Preference Disability Questionnaire, anxiety and depression by the Hospital Anxiety and Depression scale, and quality of life by the Medical Outcomes Survey Short Form 36. The most frequent LUTS among the 73 patients included (13 males) were overactive bladder (n = 11, 84.6%) and dysuria (n = 8, 61.5%) for males and overactive bladder (n = 51, 85%) and incontinence (n = 29, 48.3%) for females. Among women, 32 (53.2%) were sexually active: 20 (62.5%) had sexual disorders (mean [SD] FSFI score 16.3 [6.2]), the most compromised domains being desire (mean score 2.6 [1.3]) and arousal (mean score 2.5 [1.4]). Sexual disorders were associated with short disease duration (P = 0.01) and high depression (P = 0.04) scores. For men, 7/8 (87.5%) had erectile dysfunction (mean IIEF-5 score 16 [5.3]). LUTS seem to be more frequent in SSc patients than in the general population. The most frequent symptom was overactive bladder. Déterminer la fréquence des troubles urinaires du bas appareil (TUBA) et les troubles sexuels chez les patients ayant une sclérodermie systémique (ScS) et associer ces symptômes aux caractéristiques cliniques et fonctionnelles, incluant le handicap et la qualité de vie. Des patients ayant une ScS, suivis à l’hôpital Cochin, Paris, entre février et avril 2010, ont été évalués selon le type de sclérodermie, les TUBA avec le Urinary Symptom Profile (USP), les troubles sexuels avec le Feminine Sexual Function Index (FSFI) et le International Index for the Erectile Function (IIEF-5), le handicap global avec le Health Assessment Questionnaire et le McMaster Toronto Arthritis Patient Preference Disability Questionnaire, l’anxiété et la dépression avec le Hospital Anxiety and Depression scale et la qualité de vie avec le Medical Outcomes Survey Short Form 36. Les TUBA les plus fréquents parmi les 73 patients inclus (13 hommes) étaient l’hyperactivité vésicale (n = 11, 84,6 %) et la dysurie (n = 8, 61,5 %) chez les hommes et l’hyperactivité vésicale (n = 51, 85 %) et l’incontinence (n = 29, 48,3 %) chez les femmes. Parmi les femmes, 32 (53,2 %) étaient sexuellement actives, dont 20 (62,5 %) avaient des troubles sexuels (moyenne [DS] du FSFI de 16,3 [6,2]), les domaines plus atteints était le désir (score moyen : 2,6 [1,3]) et l’excitation (score moyen : 2,5 [1,4]). Les troubles sexuels étaient associés à une durée de la maladie plus courte (P = 0,01) et à la dépression (P = 0,04). Chez les hommes, 7/8 (87,5 %) avaient une dysfonction érectile (moyenne [DS] de l’IIEF-5 de 16 [5,3]). Les TUBA semblent être plus fréquents chez les patients ayant une ScS que dans la population générale. Le symptôme plus fréquent était l’hyperactivité vésicale." @default.
• W2306075557 created "2016-06-24" @default.
• W2306075557 creator A5007247451 @default.
• W2306075557 creator A5019109126 @default.
• W2306075557 creator A5019920991 @default.
• W2306075557 creator A5039461146 @default.
• W2306075557 creator A5045758168 @default.
• W2306075557 creator A5063397442 @default.
• W2306075557 creator A5083119810 @default.
• W2306075557 creator A5086629566 @default.
• W2306075557 creator A5089178475 @default.
• W2306075557 date "2016-04-01" @default.
• W2306075557 modified "2023-10-18" @default.
• W2306075557 title "Systemic sclerosis: Sexual dysfunction and lower urinary tract symptoms in 73 patients" @default.
• W2306075557 cites W1572523482 @default.
• W2306075557 cites W1602886608 @default.
• W2306075557 cites W1967312126 @default.
• W2306075557 cites W1967347194 @default.
• W2306075557 cites W1987138256 @default.
• W2306075557 cites W1987415356 @default.
• W2306075557 cites W1995465179 @default.
• W2306075557 cites W1995988804 @default.
• W2306075557 cites W2025520842 @default.
• W2306075557 cites W2025941853 @default.
• W2306075557 cites W2026641917 @default.
• W2306075557 cites W2032411381 @default.
• W2306075557 cites W2035137731 @default.
• W2306075557 cites W2035823248 @default.
• W2306075557 cites W2049461362 @default.
• W2306075557 cites W2054504088 @default.
• W2306075557 cites W2058264405 @default.
• W2306075557 cites W2060474668 @default.
• W2306075557 cites W2061091373 @default.
• W2306075557 cites W2065930969 @default.
• W2306075557 cites W2070436486 @default.
• W2306075557 cites W2083929867 @default.
• W2306075557 cites W2084355008 @default.
• W2306075557 cites W2087043765 @default.
• W2306075557 cites W2093667509 @default.
• W2306075557 cites W2094861980 @default.
• W2306075557 cites W2106549223 @default.
• W2306075557 cites W2107995021 @default.
• W2306075557 cites W2112997260 @default.
• W2306075557 cites W2114728329 @default.
• W2306075557 cites W2120385927 @default.
• W2306075557 cites W2137071299 @default.
• W2306075557 cites W2146225335 @default.
• W2306075557 cites W2149839143 @default.
• W2306075557 cites W2156807514 @default.
• W2306075557 cites W2162820714 @default.
• W2306075557 cites W2163802811 @default.
• W2306075557 cites W2164096595 @default.
• W2306075557 cites W2166281097 @default.
• W2306075557 cites W2508060872 @default.
• W2306075557 cites W4292806894 @default.
• W2306075557 doi "https://doi.org/10.1016/j.lpm.2015.08.009" @default.
• W2306075557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27016850" @default.
• W2306075557 hasPublicationYear "2016" @default.
• W2306075557 type Work @default.
• W2306075557 sameAs 2306075557 @default.
• W2306075557 citedByCount "15" @default.
• W2306075557 countsByYear W23060755572017 @default.
• W2306075557 countsByYear W23060755572018 @default.
• W2306075557 countsByYear W23060755572019 @default.
• W2306075557 countsByYear W23060755572020 @default.
• W2306075557 countsByYear W23060755572021 @default.
• W2306075557 countsByYear W23060755572022 @default.
• W2306075557 countsByYear W23060755572023 @default.
• W2306075557 crossrefType "journal-article" @default.
• W2306075557 hasAuthorship W2306075557A5007247451 @default.
• W2306075557 hasAuthorship W2306075557A5019109126 @default.
• W2306075557 hasAuthorship W2306075557A5019920991 @default.
• W2306075557 hasAuthorship W2306075557A5039461146 @default.
• W2306075557 hasAuthorship W2306075557A5045758168 @default.
• W2306075557 hasAuthorship W2306075557A5063397442 @default.
• W2306075557 hasAuthorship W2306075557A5083119810 @default.
• W2306075557 hasAuthorship W2306075557A5086629566 @default.
• W2306075557 hasAuthorship W2306075557A5089178475 @default.
• W2306075557 hasConcept C118552586 @default.
• W2306075557 hasConcept C121608353 @default.
• W2306075557 hasConcept C126322002 @default.
• W2306075557 hasConcept C139719470 @default.
• W2306075557 hasConcept C142724271 @default.
• W2306075557 hasConcept C159110408 @default.
• W2306075557 hasConcept C162324750 @default.
• W2306075557 hasConcept C1862650 @default.
• W2306075557 hasConcept C204787440 @default.
• W2306075557 hasConcept C2775871022 @default.
• W2306075557 hasConcept C2776235491 @default.
• W2306075557 hasConcept C2776547966 @default.
• W2306075557 hasConcept C2776845205 @default.
• W2306075557 hasConcept C2776867660 @default.
• W2306075557 hasConcept C2777333188 @default.
• W2306075557 hasConcept C2778093883 @default.
• W2306075557 hasConcept C2778739829 @default.
• W2306075557 hasConcept C2778941218 @default.
• W2306075557 hasConcept C2779478474 @default.
• W2306075557 hasConcept C2779929075 @default.

• next